Compare Ross Stores, Inc. (ROST) vs TG Therapeutics Inc (TGTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ross Stores, Inc. vs TG Therapeutics Inc — how do they compare? Ross Stores, Inc. trades at $235 (market cap $75.63B), while TG Therapeutics Inc trades at $54.06 (market cap $8.26B). The key difference: Ross Stores, Inc. is far larger — about 9.2× TG Therapeutics Inc's market cap, and Ross Stores, Inc. pays a 0.75% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ROST | TGTX | |
|---|---|---|
Market Cap | $75.63B | $8.26B |
Sector | Consumer Cyclical | Health |
52-Week High | $240.13 | $59.06 |
52-Week Low | $134.02 | $26.39 |
Enterprise Value | $76.23B | $8.50B |
Dividend Yield | 0.75% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →
